Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

F-918

Supelco

Fluoxetine hydrochloride solution

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Sign Into View Organizational & Contract Pricing

Select a Size

1 ML
¥4,920

¥4,920

Check Cart for Availability
Request a Bulk Order
All Photos(1)

Select a Size

Change View
1 ML
¥4,920

About This Item

Empirical Formula (Hill Notation):
C17H19ClF3NO
CAS Number:
56296-78-7
Molecular Weight:
345.79
MDL number:
MFCD00214288
UNSPSC Code:
41116107
NACRES:
NA.24

¥4,920

Check Cart for Availability
Request a Bulk Order

grade

certified reference material

Quality Level

300

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in methanol (as free base)

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

2-8°C

SMILES string

Cl.CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2

InChI

1S/C17H18F3NO.ClH/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20;/h2-10,16,21H,11-12H2,1H3;1H

InChI key

GIYXAJPCNFJEHY-UHFFFAOYSA-N

Gene Information

human ... SLC6A4(6532)

Related Categories

General description

A Snap-N-Spike® reference solution applicable for use in clinical toxicology, urine drug testing, or forensic analysis by LC-MS/MS or GC/MS. Fluoxetine is a pharmaceutical antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluoxetine is sold under the trade name Prozac® for treatment of psychological conditions including major depression and obsessive-compulsive disorder.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Prozac is a registered trademark of Eli Lilly and Co.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Alcohols
Hazardous rank II

ISHL Indicated Name

Substances Subject to be Indicated Names

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

F-918-CC:
F-918-1ML:4548173318523

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lauren Riggin et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 35(4), 362-369 (2013-05-11)
Fluoxetine is the selective serotonin reuptake inhibitor (SSRI) with the longest clinical use. Published reports regarding its fetal safety are contradictory. We aimed to establish the fetal safety of the drug. We performed a systematic review of the literature, searching
Kh Iu Ismaĭlova et al.
Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova, 62(6), 745-752 (2013-03-28)
Effects of increased levels of selective reuptake inhibitor fluoxetine were studied in Wistar male rats with different individual reactivity of the nervous system. Different behavioral models were used. In rats tolerant to audiogenic stress, drug administration led to a decrease
E Shahsavand-Ananloo et al.
European review for medical and pharmacological sciences, 17(9), 1155-1161 (2013-05-22)
Sleep disturbance is a common complaint in major depressive disorder (MDD) including impairment of both subjective and objective parameters. All antidepressants affect sleep architecture and quality. This trial was designed to compare the effects of short-term use of citalopram with
Susanne E Ahmari et al.
Science (New York, N.Y.), 340(6137), 1234-1239 (2013-06-08)
Although cortico-striato-thalamo-cortical (CSTC) circuit dysregulation is correlated with obsessive compulsive disorder (OCD), causation cannot be tested in humans. We used optogenetics in mice to simulate CSTC hyperactivation observed in OCD patients. Whereas acute orbitofrontal cortex (OFC)-ventromedial striatum (VMS) stimulation did
Błazej Grodner et al.
Psychiatria polska, 47(3), 511-518 (2013-07-28)
Enantiomers as a optically active forms of drugs now have a big impact on most areas of pharmacotherapy. They arouse a large interest in the field of psychiatry and especially in the treatment of depression. This is due to the
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service